Skip to main content

Table 3 Overall test of coincidence of regression lines

From: Expanded access with intravenous hydroxypropyl-β-cyclodextrin to treat children and young adults with Niemann-Pick disease type C1: a case report analysis

Patient ID Slope pre-IV Slope post-IV p-value
SEQ1 7.55 0.96 < 0.001
SEQ2 7.55 0.72 < 0.001
SEQ3 2.32 −0.97 < 0.001
SEQ4 3.60 −0.75 0.015
SEQ5 1.00 1.39 0.616
SEQ6 0 0.18 0.236
SEQ7 N/A 4.19 n/a
SEQ8 N/A 0.37 n/a
SEQ9 N/A 1.29 n/a
IV1 N/A 1 n/a
  1. Slopes were calculated independently for pre-intravenous (pre-IV) infusions and post-IV infusions, and when data was available for both, p-values were generated
  2. N/A data not available, n/a not applicable